Lucid Diagnostics Inc (LUCD) Actualités

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering PR Newswire NEW YORK, March 4, 2025 NEW...

Form 8-K - Current report

Form 8-K - Current report

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients...

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire NEW YORK, Feb. 25...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health

Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health PR Newswire NEW YORK, Feb. 20...

PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement

PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement PR Newswire NEW YORK, Feb. 18, 2025 NEW...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science &...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form S-8 - Securities to be offered to employees in employee benefit plans

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire NEW YORK, Jan. 13, 2025...